Novo Nordisk Shares Outstanding 2012-2026 | NVO

Novo Nordisk shares outstanding for the quarter ending March 31, 2026 were 4.449B, a 0.07% increase year-over-year.

  • Novo Nordisk 2025 shares outstanding were 4.448B, a 0.34% decline from 2024.
  • Novo Nordisk 2024 shares outstanding were 4.463B, a 0.71% decline from 2023.
  • Novo Nordisk 2023 shares outstanding were 4.495B, a 1.1% decline from 2022.

Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.

Novo Nordisk Shares Outstanding 2012-2026 | NVO

  • Novo Nordisk 2025 shares outstanding were 4.448B, a 0.34% decline from 2024.
  • Novo Nordisk 2024 shares outstanding were 4.463B, a 0.71% decline from 2023.
  • Novo Nordisk 2023 shares outstanding were 4.495B, a 1.1% decline from 2022.

Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$887.6B
Johnson & Johnson (JNJ)$574.4B
AbbVie (ABBV)$367.7B
Roche Holding AG (RHHBY)$318.8B
Merck (MRK)$299.9B
Novartis AG (NVS)$294B
Pfizer (PFE)$153.1B
Sanofi (SNY)$114B
Bayer (BAYRY)$46.2B
Innoviva (INVA)$1.8B